RT @JongeAcademie: Our keynote speaker this afternoon, as we debate stakeholder involvement. #IedereenBetrokken Registration 👉 https://t.co…
RT @MichelGoldman: Now is the time to rethink the way clinical research is conducted. More collaboration and more interdisciplinarity are n…
RT @ResearchUGent: Professor Goldman calling upon @JongeAcademie to develop resources on what it means to be a volunteer but also to help c…
RT @ResearchUGent: Professor Goldman calling upon @JongeAcademie to develop resources on what it means to be a volunteer but also to help c…
Professor Goldman calling upon @JongeAcademie to develop resources on what it means to be a volunteer but also to help change the current set-up of clinical research so all stakeholders (scientists, policymakers, patients, others) feel respected. #Iedereen
RT @JongeAcademie: Our keynote speaker this afternoon, as we debate stakeholder involvement. #IedereenBetrokken Registration 👉 https://t.co…
Great event coming up. Register to join us: https://t.co/4m0WOvh9ST
Our keynote speaker this afternoon, as we debate stakeholder involvement. #IedereenBetrokken Registration 👉 https://t.co/qMVUeJCKjA
Now is the time to rethink the way clinical research is conducted. More collaboration and more interdisciplinarity are needed! Will speak at 1:30 pm at the conference held by the Young Academy @KVAB Our future is in your hands! https://t.co/WzHI0H1FHu
How to define the most relevant end-points and assess the risk-benefit balance of new therapies during COVID-19 #clinicaltrials? Our colleagues @MichelGoldman and @mitchsilva argue that more attention should be given to patients' voices. Read more: https:/
RT @MichelGoldman: Patients have a key role in the collaborative fight against #COVID19 Read our piece with M Silva in @FrontMedicine @IMI…
RT @MichelGoldman: Patients have a key role in the collaborative fight against #COVID19 Read our piece with M Silva in @FrontMedicine @IMI…
Patients have a key role in the collaborative fight against #COVID19 Read our piece with M Silva in @FrontMedicine @IMI_JU @NathalieMoll @MagdaEfpia @EMA_News @medicinesforEU @EPHA_EU @EU_Health @ECDC_EU @WHO_Europe https://t.co/Wd9azP8l70
Congratulations Michel on your newly published @FrontiersIn article: https://t.co/2EszGs8peD